Poor efficacy of ranitidine bismuth citrate-based triple therapies for Helicobacter pylori eradication

被引：0
|
作者：
Uygun, A.
Kadayifci, A.
Yesilova, Z.
Ates, Y.
Safali, M.
Ilgan, S.
Bagci, S.
Dagalp, K.
机构：
[1] Gulhane Mil Med Acad, Div Gastroenterol, Ankara, Turkey
[2] Univ Gaziantep, Div Gastroenterol, Gaziantep, Turkey
[3] Gulhane Mil Med Acad, Dept Pathol, Ankara, Turkey
[4] Gulhane Mil Med Acad, Dept Nucl Med, Ankara, Turkey
来源：
HELICOBACTER | 2007年 / 12卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：429 / 430
页数：2
相关论文
共 50 条
  • [41] A multicenter, randomized, prospective study of 14 days ranitidine bismuth citrate vs. lansoprazole based triple therapies for the eradication of Helicobacter pylori in dyspeptic patients.
    Avsar, E
    Kaymakoglu, S
    Erzin, Y
    Poturoglu, S
    Dincer, D
    Tiftikci, A
    Yildirim, B
    Guliter, S
    Turkay, C
    Onuk, MD
    Yilmaz, U
    Bolukbas, C
    Ellidokuz, E
    Bektas, A
    Kocakaya, O
    Ates, Y
    GASTROENTEROLOGY, 2005, 128 (04) : A425 - A425
  • [42] Lansoprazole-based triple therapy versus ranitidine bismuth citrate-based dual therapy in the eradication of Helicobacter pylori in patients with duodenal ulcer:: A multicenter, randomized, double-dummy study
    Luzza, F
    Giglio, A
    Ciliberto, E
    Belmonte, A
    Cavaliere, C
    Saccà, N
    Frandina, C
    Fiocca, R
    Trimboli, V
    Pallone, F
    CLINICAL THERAPEUTICS, 2001, 23 (05) : 761 - 770
  • [43] Ranitidine bismuth citrate-based triple therapies after failure of the standard 'Maastricht triple therapy': a promising alternative to the quadruple therapy?
    Perri, F
    Villani, MR
    Quitadamo, M
    Annese, V
    Niro, GA
    Andriulli, A
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2001, 15 (07) : 1017 - 1022
  • [44] Ranitidine bismuth citrate in the treatment of Helicobacter Pylori infection
    Delgado, PH
    Feria, MR
    Castro, RR
    Olivares, FJM
    Rodríguez, BG
    Bautista, FJP
    Gutiérrez, JMH
    REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 2002, 94 (01) : 22 - 24
  • [45] Characteristics of Helicobacter pylori motility and survival in the presence of ranitidine bismuth citrate, bismuth citrate and ranitidine hydrochloride
    Worku, M
    Karim, QN
    GASTROENTEROLOGY, 1997, 112 (04) : A1120 - A1120
  • [46] Review article:: treatment of Helicobacter pylori infection with ranitidine bismuth citrate- or proton pump inhibitor-based triple therapies
    van Oijen, AHAM
    Verbeek, AL
    Jansen, JBMJ
    de Boer, WA
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2000, 14 (08) : 991 - 999
  • [47] The efficacy of ranitidine bismuth citrate, amoxicillin, and doxycycline or tetracycline regimens as a first-line treatment for Helicobacter pylori eradication
    Akyildiz, M.
    Akay, S.
    Musoglu, A.
    Tuncyurek, M.
    Tekin, F.
    Aydin, A.
    HELICOBACTER, 2007, 12 (04) : 433 - 433
  • [48] Omeprazole, lansoprazole or ranitidine bismuth citrate in combination with amoxicillin plus clarithromycin in Helicobacter pylori eradication
    Aydin, A
    Günsar, F
    Yilmaz, M
    Ersöz, G
    Özutemiz, Ö
    Ilter, T
    Tunçyürek, M
    GUT, 1998, 43 : A89 - A89
  • [49] Comparison of ranitidine bismuth citrate plus clarithromycin with omeprazole plus clarithromycin for the eradication of Helicobacter pylori
    Paré, P
    Farley, A
    Romàozinho, JM
    Bardhan, KD
    French, PC
    Roberts, PM
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 1999, 13 (08) : 1071 - 1078
  • [50] GR122311X (RANITIDINE BISMUTH CITRATE) WITH ANTIBIOTICS FOR THE ERADICATION OF HELICOBACTER-PYLORI
    WYETH, JW
    POUNDER, RE
    DEKOSTER, E
    MISIEWICZ, JJ
    OMORAIN, CA
    RAUWS, EAJ
    DUGGAN, AE
    GASTROENTEROLOGY, 1994, 106 (04) : A212 - A212
12345